Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double-Blind Phase 2 Trial Of RAD001 For Neurocognition In Individuals With Tuberous Sclerosis Complex

NCT01289912 is registered in ClinicalTrials.gov with Mustafa Sahin as lead sponsor.

NCT NCT01289912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01289912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double-Blind Phase 2 Trial Of RAD001 For Neurocognition In Individuals With Tuberous Sclerosis Complex
Lead sponsor
Mustafa Sahin
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2011
Completion date
December 31, 2014
Enrollment
52 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tuberous sclerosis complex